Orrick is advising Aptean, Jones Day is advising Logility Supply Chain Solutions, while Skadden is advising Lazard as financial advisor to Logility. Aptean, a global provider...
Aptean’s Acquisition of Logility
Emerson’s $7.2 Billion Acquisition of Remaining Outstanding Shares of AspenTech
Davis Polk & Wardwell is serving as legal advisor to Emerson, while Skadden, Arps, Slate, Meagher & Flom is serving as legal counsel to the AspenTech...
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Quanterix’s Acquisition of Akoya Biosciences
Covington & Burling represented Quanterix Corporation, and DLA Piper represented Akoya Biosciences in the transaction. Skadden represented Goldman Sachs & Co. LLC as financial advisor to...
Pharmacosmos Group’s Acquisition of G1 Therapeutics
Arnold & Porter Kaye Scholer advised Pharmacosmos, while Ropes & Gray and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented G1 Therapeutics on the deal....
TowerBrook and CD&R’s $8.9 Billion Acquisition R1 RCM
Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...
Merck’s Acquisition of Eyebiotech
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
Novartis’ Acquisition of MorphoSys
Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
Aventis’ Acquisition of INBRX-101
Paul, Weiss, Rifkind, Wharton and Garrison LLP is serving as legal counsel to Inhibrx, and Weil, Gotshal & Manges LLP is serving as legal counsel to...
Johnson & Johnson’s Acquisition of Ambrx Biopharma
Cravath, Swaine & Moore is serving as legal counsel to Johnson & Johnson, while Skadden is serving as legal counsel to Ambrx Biopharma on the transaction....